VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
VIEMED HEALTHCARE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$9.59+0.11 (+1.16%)
Close on Oct 19, 2026
- Market cap
- $394.40M
- P/E (TTM)
- 26.6
- Dividend yield
- –
Viemed Healthcare statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Misc Health & Allied Services, NEC companies for comparison
Valuation
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Market Cap | $365.27M | $1.11B |
| Enterprise Value | $363.61M | $1.41B |
| PE Ratio | 26.64 | 22.72 |
| PS Ratio | 1.21 | 1.60 |
| PB Ratio | 2.54 | 3.03 |
| P/TBV Ratio | 4.35 | 4.99 |
| P/FCF Ratio | 12.49 | 20.54 |
| P/OCF Ratio | 6.01 | 15.44 |
Enterprise value
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| EV / Sales | 1.21 | 1.69 |
| EV / EBITDA | 9.38 | 14.40 |
| EV / EBIT | 15.97 | 19.04 |
| EV / FCF | 12.44 | 23.16 |
Income (trailing twelve months)
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Revenue | $301.61M | $561.90M |
| Gross Profit | $173.32M | $173.32M |
| Operating Income | $22.77M | -$1.81M |
| Pretax Income | $21.18M | -$572.42K |
| Net Income | $14.50M | -$1.16M |
| EBITDA | $38.75M | -$20.72K |
| EPS (Diluted) | $0.36 | -$0.02 |
Margins
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Gross Margin | 57.5% | 33.1% |
| Operating Margin | 7.55% | -4.45% |
| Pretax Margin | 7.02% | 1.54% |
| Profit Margin | 4.81% | -2.91% |
| EBITDA Margin | 12.8% | 2.41% |
| FCF Margin | 9.69% | 3.13% |
Returns
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Return on Equity (ROE) | 10.2% | 1.84% |
| Return on Assets (ROA) | 7.46% | -3.06% |
| Return on Invested Capital (ROIC) | 12.2% | 2.11% |
| Return on Capital Employed (ROCE) | 14.6% | -0.57% |
Growth
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 25.2% | 6.92% |
| Net Income Growth (YoY) | 3.73% | 19.6% |
| EPS Growth (YoY) | 5.88% | 25.8% |
| Revenue Growth (3Y CAGR) | 24.9% | 10.9% |
| Revenue Growth (5Y CAGR) | 15.5% | 13.2% |
| EPS Growth (3Y CAGR) | 32.2% | 19.8% |
| EPS Growth (5Y CAGR) | -13.9% | 9.29% |
Balance sheet
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $10.68M | $48.71M |
| Total Debt | $7.09M | $140.00M |
| Net Cash (Debt) | $3.59M | $205.49K |
| Net Cash Per Share | $0.09 | $0.01 |
| Equity (Book Value) | $144.03M | $235.16M |
| Book Value Per Share | $3.78 | $3.48 |
| Tangible Book Value | $83.93M | $703.69K |
| Working Capital | $6.07M | $30.48M |
Financial position
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Current Ratio | 1.13 | 1.40 |
| Quick Ratio | 0.90 | 1.02 |
| Debt / Equity | 0.05 | 0.66 |
| Debt / EBITDA | 0.18 | 2.61 |
| Debt / FCF | 0.24 | 4.59 |
| Net Debt / EBITDA | -0.09 | 2.15 |
Cash flow (trailing twelve months)
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Operating Cash Flow | $60.78M | $3.10M |
| Capital Expenditures | -$31.55M | -$18.62M |
| Free Cash Flow | $29.24M | $23.73M |
| FCF Per Share | $0.77 | $0.37 |
Efficiency
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Asset Turnover | 1.55 | 0.87 |
| Inventory Turnover | 26.75 | 11.67 |
| Revenue Per Employee | $218.24K | $228.48K |
| Profits Per Employee | $10.49K | -$5.75K |
| Employee Count | 1,382 | 910 |
Dividends and yields
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Earnings Yield | 3.97% | -0.59% |
| FCF Yield | 8.00% | 1.74% |
| Buyback Yield | 5.02% | 0.32% |
| Shareholder Yield | 5.02% | 0.65% |
Shares
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Shares Outstanding | 38,088,200 | 58,282,400 |
| Shares Change (YoY) | -1.49% | 2.68% |
| Shares Change (QoQ) | -1.16% | 0.32% |
| Float | 32,218,000 | 33,780,100 |
| Shares Held by Insiders | 15.4% | 16.4% |
| Shares Held by Institutions | 71.3% | 85.9% |
Taxes
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Income Tax | $6.16M | $697.00K |
| Effective Tax Rate | 29.1% | 23.1% |
Scores
| Measure | Viemed Healthcare | Industry median |
|---|---|---|
| Graham Number | $5.53 | $19.59 |
| Graham Upside | -42.3% | -47.5% |
| Altman Z-Score | 6.38 | 2.05 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -3.18 | -2.71 |
Calculated by StockData from Viemed Healthcare's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.